Delivery Order SPE2DR25D1100-SPE2DR26FCS5S
Award Date 12/3/25
Potential Completion Date 12/4/25
Potential Value $8.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,771.92 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 2, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated capability to compete openly for...
- The Defense Logistics Agency awarded a $10,143.10 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials, with an ultimate completion date of December 9, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- On September 8, 2025, the Defense Logistics Agency awarded a delivery order valued at $6,343.94 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml vials. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The product will be delivered...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml quantities, with a ceiling value of $1,516.70. This competitively awarded, firm fixed-price delivery order, which has no set-aside designation, is scheduled for ultimate completion on November 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $91,757.94 for Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The order represents a single pharmaceutical supply transaction under...
- The Defense Logistics Agency awarded a $36,749.58 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 9, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials, with a ceiling value of $1,957.32. This competitive, firm fixed-price delivery order is set to be completed by August 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under a larger contract vehicle, reflecting the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $4,853.44 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitive, non-set-aside contract was awarded on November 12, 2025, with an ultimate completion date of November 13, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order operates under a firm fixed price structure and represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $35,750.42 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitive award, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, utilizes a firm fixed-price contract type with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Ozempic (0.25-0.5 mg/dose pen, 3mL) with a ceiling value of $31,330.28. The contract utilizes firm fixed price pricing and is classified as a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical products will be delivered to the company's facility in Conshohocken, Pennsylvania, with...